| 1 | O75899 | GABBR2 | T42446 | Successful Target | - Depression
- Epilepsy/seizure
- Multiple sclerosis
- Narcolepsy
| - [ICD-11: 6A70-6A7Z]
- [ICD-11: 8A61-8A6Z]
- [ICD-11: 8A40]
- [ICD-11: 7A20]
| - Mental, behavioural or neurodevelopmental disorders
- Diseases of the nervous system
- Diseases of the nervous system
- Sleep-wake disorders
|
| 2 | O15075 | DCLK1 | T42447 | Literature-reported Target |
| 3 | Q93009 | USP7 | T42658 | Preclinical target | - Postoperative inflammation
- Solid tumour/cancer
| - [ICD-11: 1A00-CA43]
- [ICD-11: 2A00-2F9Z]
|
| 4 | O15554 | KCNN4 | T42724 | Clinical trial target | - Alzheimer disease
- Chronic pain
| - [ICD-11: 8A20]
- [ICD-11: MG30]
| - Diseases of the nervous system
- Symptoms, signs or clinical findings, not elsewhere classified
|
| 5 | Q9UBS0 | RPS6KB2 | T42760 | Clinical trial target |
| 6 | Q96PY6 | NEK1 | T43031 | Literature-reported Target |
| 7 | P08575 | PTPRC | T43115 | Clinical trial target | - Acute myeloid leukaemia
- Transplanted organ/tissue
| - [ICD-11: 2A60]
- [ICD-11: QB63]
|
| 8 | P35398 | RORA | T43206 | Preclinical target | - Liver cancer
- Type 2 diabetes mellitus
| - [ICD-11: 2C12]
- [ICD-11: 5A11]
| - Neoplasms
- Endocrine, nutritional or metabolic diseases
|
| 9 | O60259 | KLK8 | T43289 | Literature-reported Target |
| 10 | P08709 | F7 | T43332 | Successful Target |
| 11 | P80365 | HSD11B2 | T43721 | Clinical trial target |
| 12 | Q9Y5Y9 | SCN10A | T43739 | Successful Target | - Corneal disease
- Human immunodeficiency virus disease
- Sensation disturbance
- Substance abuse
| - [ICD-11: 9A76-9A78]
- [ICD-11: 1C60-1C62]
- [ICD-11: MB40]
- [ICD-11: 6C40]
| - Diseases of the visual system
- Certain infectious or parasitic diseases
- Symptoms, signs or clinical findings, not elsewhere classified
- Mental, behavioural or neurodevelopmental disorders
|
| 13 | P14061 | HSD17B1 | T44011 | Clinical trial target |
| 14 | P08588 | ADRB1 | T44068 | Successful Target | - Allergic/hypersensitivity disorder
- Asthma
- Cardiac arrhythmia
- Central and peripheral nervous disease
- Circulatory system disease
- Conduction disorder
- Coronary atherosclerosis
- Essential hypertension
- Glaucoma
- Heart failure
- Hypertension
- Migraine
- Sepsis
- Supraventricular tachyarrhythmia
- Ventricular tachyarrhythmia
| - [ICD-11: 4A80-4A8Z]
- [ICD-11: CA23]
- [ICD-11: BC9Z]
- [ICD-11: 8A04-8E7Z]
- [ICD-11: BE2Z]
- [ICD-11: BC63]
- [ICD-11: BA52]
- [ICD-11: BA00]
- [ICD-11: 9C61]
- [ICD-11: BD10-BD1Z]
- [ICD-11: BA00-BA04]
- [ICD-11: 8A80]
- [ICD-11: 1G40-1G41]
- [ICD-11: BC81]
- [ICD-11: BC71]
| - Diseases of the immune system
- Diseases of the respiratory system
- Diseases of the circulatory system
- Diseases of the nervous system
- Diseases of the circulatory system
- Diseases of the circulatory system
- Diseases of the circulatory system
- Diseases of the circulatory system
- Diseases of the visual system
- Diseases of the circulatory system
- Diseases of the circulatory system
- Diseases of the nervous system
- Certain infectious or parasitic diseases
- Diseases of the circulatory system
- Diseases of the circulatory system
|
| 15 | Q92772 | CDKL2 | T44341 | Literature-reported Target |
| 16 | O15146 | MUSK | T44387 | Literature-reported Target |
| 17 | P50750 | CDK9 | T44458 | Clinical trial target | - Acute myeloid leukaemia
- Lymphoma
- Malignant haematopoietic neoplasm
- Mature B-cell leukaemia
- Mature B-cell lymphoma
- Non-alcoholic fatty liver disease
- Solid tumour/cancer
| - [ICD-11: 2A60]
- [ICD-11: 2A80-2A86]
- [ICD-11: 2B33]
- [ICD-11: 2A82]
- [ICD-11: 2A85]
- [ICD-11: DB92]
- [ICD-11: 2A00-2F9Z]
|
| 18 | Q14721 | KCNB1 | T44516 | Literature-reported Target |
| 19 | P48775 | TDO2 | T44818 | Clinical trial target |
| 20 | Q05655 | PRKCD | T44861 | Clinical trial target |
| 21 | P01275 | GCG | T44919 | Clinical trial target | - Acute diabete complication
- Diabetes mellitus
- Obesity
- Parkinsonism
- Type 2 diabetes mellitus
| - [ICD-11: 5A2Y]
- [ICD-11: 5A10]
- [ICD-11: 5B80-5B81]
- [ICD-11: 8A00]
- [ICD-11: 5A11]
| - Endocrine, nutritional or metabolic diseases
- Endocrine, nutritional or metabolic diseases
- Endocrine, nutritional or metabolic diseases
- Diseases of the nervous system
- Endocrine, nutritional or metabolic diseases
|
| 22 | P19320 | VCAM1 | T44991 | Literature-reported Target |
| 23 | Q96T53 | FKSG89 | T45228 | Patented-recorded Target | - Obesity
- Type 2 diabetes mellitus
| - [ICD-11: 5B80-5B81]
- [ICD-11: 5A11]
| - Endocrine, nutritional or metabolic diseases
- Endocrine, nutritional or metabolic diseases
|
| 24 | P34998 | CRHR1 | T45262 | Successful Target |
| 25 | Q9ULA0 | DNPEP | T45287 | Clinical trial target |